Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/18956
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBerkovic, Samuel F-
dc.date.accessioned2018-09-12T23:55:42Z-
dc.date.available2018-09-12T23:55:42Z-
dc.date.issued2017-
dc.identifier.citationThe New England Journal of Medicine 2017; 376(21): 2075-2076-
dc.identifier.urihttps://ahro.austin.org.au/austinjspui/handle/1/18956-
dc.language.isoeng-
dc.titleCannabinoids for Epilepsy - Real Data, at Last.-
dc.typeJournal Article-
dc.identifier.journaltitleThe New England Journal of Medicine-
dc.identifier.affiliationEpilepsy Research Centre, Department of Medicine, Austin Health, The University of Melbourne, Heidelberg, Victoria, Australia-
dc.identifier.doi10.1056/NEJMe1702205-
dc.identifier.orcid0000-0003-4580-841X-
dc.identifier.pubmedid28538129-
dc.type.austinEditorial-
dc.type.austinComment-
local.name.researcherBerkovic, Samuel F
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.openairetypeJournal Article-
item.grantfulltextnone-
item.cerifentitytypePublications-
item.fulltextNo Fulltext-
item.languageiso639-1en-
crisitem.author.deptEpilepsy Research Centre-
crisitem.author.deptNeurology-
Appears in Collections:Journal articles
Show simple item record

Page view(s)

18
checked on Oct 2, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.